336 related articles for article (PubMed ID: 37236756)
21. Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.
Abeywardena MY; Patten GS
Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):232-46. PubMed ID: 21831036
[TBL] [Abstract][Full Text] [Related]
22. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
[TBL] [Abstract][Full Text] [Related]
23. Arachidonic acid does not share the antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids in a model of angiotensin II-induced hypertension in the rat.
Hui R; Robillard M; Grose JH; Lebel M; Falardeau P
Clin Invest Med; 1991 Dec; 14(6):518-24. PubMed ID: 1794205
[TBL] [Abstract][Full Text] [Related]
24. [Lipids, depression and suicide].
Colin A; Reggers J; Castronovo V; Ansseau M
Encephale; 2003; 29(1):49-58. PubMed ID: 12640327
[TBL] [Abstract][Full Text] [Related]
25. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.
Nayeem MA; Geldenhuys WJ; Hanif A
Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 fatty acids and inflammatory processes: from molecules to man.
Calder PC
Biochem Soc Trans; 2017 Oct; 45(5):1105-1115. PubMed ID: 28900017
[TBL] [Abstract][Full Text] [Related]
27. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
28. Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy.
Hu C; Kong H; Qu F; Li Y; Yu Z; Gao P; Peng S; Xu G
Mol Biosyst; 2011 Dec; 7(12):3271-9. PubMed ID: 22009255
[TBL] [Abstract][Full Text] [Related]
29. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina.
SanGiovanni JP; Chew EY
Prog Retin Eye Res; 2005 Jan; 24(1):87-138. PubMed ID: 15555528
[TBL] [Abstract][Full Text] [Related]
30. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction.
Mori TA; Beilin LJ
Curr Opin Lipidol; 2001 Feb; 12(1):11-7. PubMed ID: 11176197
[TBL] [Abstract][Full Text] [Related]
31. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects.
Mori TA; Bao DQ; Burke V; Puddey IB; Watts GF; Beilin LJ
Am J Clin Nutr; 1999 Nov; 70(5):817-25. PubMed ID: 10539741
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review.
Saini RK; Keum YS
Life Sci; 2018 Jun; 203():255-267. PubMed ID: 29715470
[TBL] [Abstract][Full Text] [Related]
33. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
34. Dietary fish protein lowers blood pressure and alters tissue polyunsaturated fatty acid composition in spontaneously hypertensive rats.
Ait-Yahia D; Madani S; Savelli JL; Prost J; Bouchenak M; Belleville J
Nutrition; 2003 Apr; 19(4):342-6. PubMed ID: 12679169
[TBL] [Abstract][Full Text] [Related]
35. The role of the cytochrome P450-dependent metabolites of arachidonic acid in blood pressure regulation and renal function: a review.
Rahman M; Wright JT; Douglas JG
Am J Hypertens; 1997 Mar; 10(3):356-65. PubMed ID: 9056695
[TBL] [Abstract][Full Text] [Related]
36. Orally active epoxyeicosatrienoic acid analogs in hypertension and renal injury.
Imig JD
Adv Pharmacol; 2022; 94():27-55. PubMed ID: 35659375
[TBL] [Abstract][Full Text] [Related]
37. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
38. Omega-3 carboxylic acids and fenofibrate differentially alter plasma lipid mediators in patients with non-alcoholic fatty liver disease.
Camacho-Muñoz D; Kiezel-Tsugunova M; Kiss O; Uddin M; Sundén M; Ryaboshapkina M; Lind L; Oscarsson J; Nicolaou A
FASEB J; 2021 Nov; 35(11):e21976. PubMed ID: 34618982
[TBL] [Abstract][Full Text] [Related]
39. Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids.
Colussi G; Catena C; Fagotto V; Darsiè D; Brosolo G; Bertin N; Sechi LA
Crit Rev Food Sci Nutr; 2019; 59(12):1937-1948. PubMed ID: 29381383
[TBL] [Abstract][Full Text] [Related]
40. Lowering Effects of n-3 Fatty Acid Supplements on Blood Pressure by Reducing Plasma Angiotensin II in Inner Mongolia Hypertensive Patients: A Double-Blind Randomized Controlled Trial.
Yang B; Shi L; Wang AM; Shi MQ; Li ZH; Zhao F; Guo XJ; Li D
J Agric Food Chem; 2019 Jan; 67(1):184-192. PubMed ID: 30511840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
